Tuning the anticancer activity of a novel pro-apoptotic peptide using gold nanoparticle platforms

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Akrami, Mohammad ^a   Balalaie, Saeed ^b   Hosseinkhani, Saman ^c   Alipour, Mohsen ^c   Salehi, Fahimeh ^d   Bahador, Abbas ^e   Haririan, Ismaeil ^a,f  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b K N TOOSI UNIVERSITY OF TECHNOLOGY   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

^d UNIVERSITY OF TEHRAN   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; GOLD; METAL NANOPARTICLE; OLIGOPEPTIDE; THIOCTIC ACID;

ACTIVE TRANSPORT; AMINO ACID SEQUENCE; APOPTOSIS; CHEMISTRY; DRUG EFFECTS; FEMALE; HEMOLYSIS; HUMAN; IN VITRO STUDY; MCF-7 CELL LINE; PARTICLE SIZE; TUMOR CELL LINE; ULTRASTRUCTURE;

AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE, TUMOR; FEMALE; GOLD; HEMOLYSIS; HUMANS; IN VITRO TECHNIQUES; MCF-7 CELLS; METAL NANOPARTICLES; OLIGOPEPTIDES; PARTICLE SIZE; THIOCTIC ACID;

EID: 84982803503     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31030     Document Type: Article

References (57)

1. Vlieghe, P., Lisowski, V., Martinez, J., Khrestchatisky, M. Synthetic therapeutic peptides: science and market. Drug Discovery Today 15, 40-56, http://dx.doi.org/10.1016/j.drudis.2009.10.009 (2010).
2. Thundimadathil, J. Cancer Treatment Using Peptides: Current Therapies and Future Prospects. Journal of Amino Acids 1-13 (2012).
3. Schweizer, F. Cationic amphiphilic peptides with cancer-selective toxicity. European Journal of Pharmacology 625, 190-194, http://dx.doi.org/10.1016/j.ejphar.2009.08.043 (2009).
4. Chen, W.-H. et al. Dual-Targeting Pro-apoptotic Peptide for Programmed Cancer Cell Death via Specific Mitochondria Damage. Scientific Reports 3, 3468, doi: 10.1038/srep03468 http://www.nature.com/articles/srep03468#supplementary-information (2013).
5. Indran, I. R., Tufo, G., Pervaiz, S., Brenner, C. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochimica et biophysica acta 1807, 735-745, doi: 10.1016/j.bbabio.2011.03.010 (2011).
6. Mai, J. C., Mi, Z., Kim, S.-H., Ng, B., Robbins, P. D. A Proapoptotic Peptide for the Treatment of Solid Tumors. Cancer Research 61, 7709-7712 (2001).
7. Duncan, B., Kim, C., Rotello, V. M. Gold nanoparticle platforms as drug and biomacromolecule delivery systems. Journal of Controlled Release 148, 122-127, http://dx.doi.org/10.1016/j.jconrel.2010.06.004 (2010).
8. Lin, Y.-C. et al. Multidimensional Design of Anticancer Peptides. Angewandte Chemie International Edition 54, 10370-10374, doi: 10.1002/anie.201504018 (2015).
9. Liu, S., Yang, H., Wan, L., Cheng, J., Lu, X. Penetratin-mediated delivery enhances the antitumor activity of the cationic antimicrobial peptide Magainin II. Cancer biotherapy & radiopharmaceuticals 28, 289-297, doi: 10.1089/cbr.2012.1328 (2013).
10. Delong, R. K. et al. Functionalized gold nanoparticles for the binding, stabilization, delivery of therapeutic DNA, RNA, other biological macromolecules. Nanotechnol Sci Appl. 3, 53-63, doi: 10.2147/nsa.s8984 (2010).
11. Arvizo, R., Bhattacharya, R., Mukherjee, P. Gold nanoparticles: opportunities and challenges in nanomedicine. Expert opinion on drug delivery 7, 753-763, doi: 10.1517/17425241003777010 (2010).
12. Tiwari, P., Vig, K., Dennis, V., Singh, S. Functionalized Gold Nanoparticles and Their Biomedical Applications. Nanomaterials 1, 31 (2011).
13. Liopo, A. et al. Biocompatible Gold Nanorod Conjugates for Preclinical Biomedical Research. Journal of nanomedicine & nanotechnology S2, doi: 10.4172/2157-7439.s2-001 (2012).
14. Dreaden, E. C., Austin, L. A., Mackey, M. A., El-Sayed, M. A. Size matters: gold nanoparticles in targeted cancer drug delivery. Therapeutic delivery 3, 457-478 (2012).
15. Vigderman, L., Zubarev, E. R. Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules. Advanced Drug Delivery Reviews 65, 663-676, http://dx.doi.org/10.1016/j.addr.2012.05.004 (2013).
16. Jiao, P. F., Zhou, H. Y., Chen, L. X., Yan, B. Cancer-targeting multifunctionalized gold nanoparticles in imaging and therapy. Curr Med Chem. 18, 2086-2102 (2011).
17. Dai, Q., Coutts, J., Zou, J., Huo, Q. Surface modification of gold nanorods through a place exchange reaction inside an ionic exchange resin. Chemical Communications 2858-2860, doi: 10.1039/B804797A (2008).
18. Gui, C., Cui, D. X. Functionalized gold nanorods for tumor imaging and targeted therapy. Cancer Biol Med. 9, 221-233, doi: 10.7497/j.issn.2095-3941.2012.04.002 (2012).
19. Mitamura, K., Imae, T. Functionalization of Gold Nanorods Toward Their Applications. Plasmonics 4, 23-30, doi: 10.1007/s11468-008-9073-z (2008).
20. Letsinger, R. L., Elghanian, R., Viswanadham, G., Mirkin, C. A. Use of a steroid cyclic disulfide anchor in constructing gold nanoparticle-oligonucleotide conjugates. Bioconjugate chemistry 11, 289-291 (2000).
21. Nguyen T. K. Thanha, b & Luke A. W. Greena Functionalisation of nanoparticles for biomedical applications. Nano Today 5, 213-230 (2010).
22. Chanda, N., Shukla, R., Katti, K. V., Kannan, R. Gastrin releasing protein receptor specific gold nanorods: breast and prostate tumor avid nanovectors for molecular imaging. Nano Lett 9, 1798-1805, doi: 10.1021/nl8037147 (2009).
23. Sperling, R. A., Parak, W. J. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philosophical Transactions of the Royal Society of London A: Mathematical, Physical and Engineering Sciences 368, 1333-1383, doi: 10.1098/rsta.2009.0273 (2010).
24. Hwang, S.-Y., Tao Andrea, R. In Pure and Applied Chemistry 83, 233 (2010).
25. Jiang, W., KimBetty, Y. S., Rutka, J. T., ChanWarren, C. W. Nanoparticle-mediated cellular response is size-dependent. Nat Nano 3, 145-150, http://www.nature.com/nnano/journal/v3/n3/suppinfo/nnano.2008.30-S1.html (2008).
26. Ma, X., Wang, X., Zhou, M., Fei, H. A mitochondria-targeting gold-peptide nanoassembly for enhanced cancer-cell killing. Advanced healthcare materials 2, 1638-1643, doi: 10.1002/adhm.201300037 (2013).
27. Shagaghi, N., Palombo, E. A., Clayton, A. H., Bhave, M. Archetypal tryptophan-rich antimicrobial peptides: properties and applications. World journal of microbiology & biotechnology 32, 31, doi: 10.1007/s11274-015-1986-z (2016).
28. Javadpour, M. M. et al. De novo antimicrobial peptides with low mammalian cell toxicity. Journal of medicinal chemistry 39, 3107-3113, doi: 10.1021/jm9509410 (1996).
29. Sau, T. K., Murphy, C. J. Seeded High Yield Synthesis of Short Au Nanorods in Aqueous Solution. Langmuir 20, 6414-6420, doi: 10.1021/la049463z (2004).
30. Thierry, B., Ng, J., Krieg, T., Griesser, H. J. A robust procedure for the functionalization of gold nanorods and noble metal nanoparticles. Chemical Communications 1724-1726, doi: 10.1039/B820137D (2009).
31. Ghosh, P., Han, G., De, M., Kim, C. K., Rotello, V. M. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev. 60, 1307-1315, doi: 10.1016/j.addr.2008.03.016 (2008).
32. Huang, X., Neretina, S., El-Sayed, M. A. Gold Nanorods: From Synthesis and Properties to Biological and Biomedical Applications. Advanced Materials 21, 4880-4910, doi: 10.1002/adma.200802789 (2009).
33. Liu, X. et al. Multidentate zwitterionic chitosan oligosaccharide modified gold nanoparticles: stability, biocompatibility and cell interactions. Nanoscale 5, 3982-3991, doi: 10.1039/c3nr00284e (2013).
34. Krpeti, Ž., Nativo, P., Porta, F., Brust, M. A Multidentate Peptide for Stabilization and Facile Bioconjugation of Gold Nanoparticles. Bioconjugate chemistry 20, 619-624, doi: 10.1021/bc8003028 (2009).
35. Porta, F. et al. Gold nanoparticles capped by peptides. Materials Science and Engineering: B 140, 187-194, http://dx.doi. org/10.1016/j.mseb.2007.03.019 (2007).
36. Dorchioiu, A. A. a. G. Rapid characterization of peptide secondary structure by FT-IR spectroscopy. Rev. Roum. Chim. 56, 783-791 (2011).
37. Szebeni, J. In European Journal of Nanomedicine 4, 33 (2012).
38. Chen, D. et al. Biocompatibility of magnetic Fe(3)O(4) nanoparticles and their cytotoxic effect on MCF-7 cells. International Journal of Nanomedicine 7, 4973-4982, doi: 10.2147/IJN.S35140 (2012).
39. Indran, I. R., Tufo, G., Pervaiz, S., Brenner, C. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochimica et Biophysica Acta (BBA)-Bioenergetics 1807, 735-745, http://dx.doi.org/10.1016/j.bbabio.2011.03.010 (2011).
40. Chen, W.-H. et al. A new anti-cancer strategy of damaging mitochondria by pro-apoptotic peptide functionalized gold nanoparticles. Chemical Communications 49, 6403-6405, doi: 10.1039/C3CC43283A (2013).
41. Mkandawire, M. M. et al. Induction of apoptosis in human cancer cells by targeting mitochondria with gold nanoparticles. Nanoscale 7, 10634-10640, doi: 10.1039/C5NR01483B (2015).
42. Yu-Feng Xiao, M.-M. J., Bo-Sheng Li, Chang-Jiang Hu, Rui Xie, Bo Tang & Shi-Ming Yang. Peptide-Based Treatment: A Promising Cancer Therapy. Journal of Immunology Research 1-13 (2015).
43. Hoskin, D. W., Ramamoorthy, A. Studies on anticancer activities of antimicrobial peptides. Biochimica et Biophysica Acta (BBA)-Biomembranes 1778, 357-375, http://dx.doi.org/10.1016/j.bbamem.2007.11.008 (2008).
44. Moktan, S., Raucher, D. Anticancer Activity of Proapoptotic Peptides is Highly Improved by Thermal Targeting using Elastin-like Polypeptides. International Journal of Peptide Research and Therapeutics 18, 227-237, doi: 10.1007/s10989-012-9295-y (2012).
45. Mulder, K. C., Lima, L. A., Miranda, V. J., Dias, S. C., Franco, O. L. Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides. Frontiers in microbiology 4, 321, doi: 10.3389/fmicb.2013.00321 (2013).
46. Cho, E. C., Au, L., Zhang, Q., Xia, Y. The Effects of Size, Shape, Surface Functional Group of Gold Nanostructures on Their Adsorption and Internalization by Cells. Small 6, 517-522, doi: 10.1002/smll.200901622 (2010).
47. Chithrani, B. D., Ghazani, A. A., Chan, W. C. W. Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells. Nano Letters 6, 662-668, doi: 10.1021/nl052396o (2006).
48. Hill, H. D., Millstone, J. E., Banholzer, M. J., Mirkin, C. A. The Role Radius of Curvature Plays in Thiolated Oligonucleotide Loading on Gold Nanoparticles. ACS Nano 3, 418-424, doi: 10.1021/nn800726e (2009).
49. Mandal, H. S., Kraatz, H. B. Effect of the surface curvature on the secondary structure of peptides adsorbed on nanoparticles. J Am Chem Soc. 129, 6356-6357, doi: 10.1021/ja0703372 (2007).
50. Dobrovolskaia, M. A. et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine: Nanotechnology, Biology and Medicine 5, 106-117, doi: 10.1016/j.nano.2008.08.001.
51. Mirsadeghi, S. et al. Protein corona composition of gold nanoparticles/nanorods affects amyloid beta fibrillation process. Nanoscale 7, 5004-5013, doi: 10.1039/C4NR06009A (2015).
52. AntiCP: Designing of Anticancer Peptides, Institute of microbial technology, chandigarch, India. (http://crdd.osdd.net/raghava/anticp/.).
53. Tahoori, F., Sheikhnejad, R., Balalaie, S., Sadjadi, M. Synthesis of novel peptides through Ugi-ligation and their anti-cancer activities. Amino Acids 45, 975-981, doi: 10.1007/s00726-013-1554-5 (2013).
54. Tahoori, F., Balalaie, S., Sheikhnejad, R., Sadjadi, M., Boloori, P. Design and synthesis of anti-cancer cyclopeptides containing triazole skeleton. Amino Acids 46, 1033-1046, doi: 10.1007/s00726-013-1663-1 (2014).
55. Yang, J. et al. The I-TASSER Suite: protein structure and function prediction. Nat Meth. 12, 7-8, doi: 10.1038/nmeth.3213 http://www.nature.com/nmeth/journal/v12/n1/abs/nmeth.3213.html#supplementary-information (2015).
56. Akrami, M. et al. Evaluation of multilayer coated magnetic nanoparticles as biocompatible curcumin delivery platforms for breast cancer treatment. RSC Advances 5, 88096-88107, doi: 10.1039/C5RA13838H (2015).
57. Akbari-Birgani, S., Hosseinkhani, S., Mollamohamadi, S., Baharvand, H. Delay in Apoptosome Formation Attenuates Apoptosis in Mouse Embryonic Stem Cell Differentiation. Journal of Biological Chemistry 289, 16905-16913, doi: 10.1074/jbc.M113.536730 (2014).